Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion suggests that PCOS may persist due to genetic traits that, while harmful for female fertility, could have provided survival and reproductive benefits to males.

Shrinking of oil glands in the skin is a key sign of hair loss linked to TNF inhibitor drugs and may improve if the treatment is stopped.

MED1 affects skin wound healing differently in young and old mice.

The document concludes that there are still unknowns about the effectiveness, risks, and detection of performance-enhancing drugs, and doping remains a challenge.

Angiogenin helps hair grow by stimulating cell growth and blood vessel formation.

The conclusion is that skin and hair patterns are formed by a mix of cell activities, molecular signals, and environmental factors.

Lifestyle changes are the first step in treating infertility in PCOS, followed by medications like clomiphene and metformin, and then surgery if needed.

Using systemic drugs as creams for skin conditions shows promise, but more research is needed to confirm their effectiveness and safety.

New chemotherapy drugs cause skin side effects, but treatments like minocycline and tetracycline can help reduce them.

Some chemicals absorbed through the skin can cause serious health problems.

Inositol was not more effective than a placebo in treating trichotillomania.

Wnt/β-catenin and TGF-β pathways affect hair loss, and activating Wnt/β-catenin could be a potential treatment.

Advancements in male reproductive medicine are ongoing, but more research and improved treatments are needed in several areas.

Certain proteins and their receptors are more active during the growth phase of human hair and could be targeted to treat hair disorders.

Finasteride reduces inflammation and improves immune response after trauma by altering hormone levels.

Low testosterone in men is a risk factor for a specific heart rhythm issue, and testosterone treatment may help prevent it.

Animal models are crucial for learning about hair loss and finding treatments.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

Cimetidine did not reduce hair growth in women with hirsutism.

A new therapy sped up wound healing and reduced scarring in diabetic rats.

Certain genetic markers linked to reproductive potential were identified by their impact on a protein's ability to bind to genes.

The document concludes that side effects from Smoothened inhibitor drugs for skin cancer are reversible and can be managed with a team approach to maintain quality of life.

The document suggests various treatments for PCOS, including medication for menstrual issues, insulin resistance, and excess hair, as well as fertility treatments, while highlighting the need for personalized care and lifestyle changes.

Hormone imbalances can cause skin diseases, and understanding these links is important for diagnosis and treatment.

A woman with lupus experienced skin death due to a blood clotting disorder after stopping a blood thinner, which healed with treatment.

Antiandrogen drugs can reduce PSA levels in women with excess hair, suggesting PSA is a sign of male hormone activity in women.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Substances from dental stem cells might help treat hair loss.

Finasteride and dutasteride are effective for long-term treatment of enlarged prostates but have sexual side effects and a risk of high-grade prostate cancer.

Using PGPR as biofertilizers can improve soil health and plant growth while reducing reliance on synthetic fertilizers.